These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 15521362)
1. Dopamine receptor microdomains involved in molecular recognition and the regulation of drug affinity and function. Floresca CZ; Schetz JA J Recept Signal Transduct Res; 2004 Aug; 24(3):207-39. PubMed ID: 15521362 [TBL] [Abstract][Full Text] [Related]
2. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Schotte A; Janssen PF; Gommeren W; Luyten WH; Van Gompel P; Lesage AS; De Loore K; Leysen JE Psychopharmacology (Berl); 1996 Mar; 124(1-2):57-73. PubMed ID: 8935801 [TBL] [Abstract][Full Text] [Related]
3. Dopamine D4/D2 receptor selectivity is determined by A divergent aromatic microdomain contained within the second, third, and seventh membrane-spanning segments. Simpson MM; Ballesteros JA; Chiappa V; Chen J; Suehiro M; Hartman DS; Godel T; Snyder LA; Sakmar TP; Javitch JA Mol Pharmacol; 1999 Dec; 56(6):1116-26. PubMed ID: 10570038 [TBL] [Abstract][Full Text] [Related]
4. Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications. Lahti RA; Evans DL; Stratman NC; Figur LM Eur J Pharmacol; 1993 Jun; 236(3):483-6. PubMed ID: 8102973 [TBL] [Abstract][Full Text] [Related]
5. Behavioral Analysis of Dopaminergic Activation in Zebrafish and Rats Reveals Similar Phenotypes. Ek F; Malo M; Åberg Andersson M; Wedding C; Kronborg J; Svensson P; Waters S; Petersson P; Olsson R ACS Chem Neurosci; 2016 May; 7(5):633-46. PubMed ID: 26947759 [TBL] [Abstract][Full Text] [Related]
6. Reciprocal mutations in TM2/TM3 in a D2 dopamine receptor background confirms the importance of this microdomain as a selective determinant of para-halogenated 1,4-disubstituted aromatic piperazines. Floresca CZ; Chen S; Kortagere S; Schetz JA Arch Pharm (Weinheim); 2005 Jun; 338(5-6):268-75. PubMed ID: 15952239 [TBL] [Abstract][Full Text] [Related]
7. Characterization of the binding of SCH 39166 to the five cloned dopamine receptor subtypes. Tice MA; Hashemi T; Taylor LA; Duffy RA; McQuade RD Pharmacol Biochem Behav; 1994 Nov; 49(3):567-71. PubMed ID: 7862709 [TBL] [Abstract][Full Text] [Related]
8. Amisulpride the 'atypical' atypical antipsychotic--comparison to haloperidol, risperidone and clozapine. Natesan S; Reckless GE; Barlow KB; Nobrega JN; Kapur S Schizophr Res; 2008 Oct; 105(1-3):224-35. PubMed ID: 18710798 [TBL] [Abstract][Full Text] [Related]
9. A Complete Assessment of Dopamine Receptor- Ligand Interactions through Computational Methods. Bueschbell B; Barreto CAV; Preto AJ; Schiedel AC; Moreira IS Molecules; 2019 Mar; 24(7):. PubMed ID: 30934701 [No Abstract] [Full Text] [Related]
10. Transmembrane segment five serines of the D4 dopamine receptor uniquely influence the interactions of dopamine, norepinephrine, and Ro10-4548. Cummings DF; Ericksen SS; Goetz A; Schetz JA J Pharmacol Exp Ther; 2010 Jun; 333(3):682-95. PubMed ID: 20215412 [TBL] [Abstract][Full Text] [Related]
11. The binding of agonists and antagonists to dopamine receptors. Strange PG Biochem Soc Trans; 1996 Feb; 24(1):188-92. PubMed ID: 8674658 [No Abstract] [Full Text] [Related]
12. Nonconserved residues in the second transmembrane-spanning domain of the D(4) dopamine receptor are molecular determinants of D(4)-selective pharmacology. Schetz JA; Benjamin PS; Sibley DR Mol Pharmacol; 2000 Jan; 57(1):144-52. PubMed ID: 10617689 [TBL] [Abstract][Full Text] [Related]
13. Molecular modeling of the dopamine D2 and serotonin 5-HT1A receptor binding modes of the enantiomers of 5-OMe-BPAT. Homan EJ; Wikström HV; Grol CJ Bioorg Med Chem; 1999 Sep; 7(9):1805-20. PubMed ID: 10530928 [TBL] [Abstract][Full Text] [Related]
14. [3H]Clozapine is not a suitable radioligand for the labelling of D4 dopamine receptors in postmortem human brain. Flamez A; de Backer JP; Wilczak N; Vauquelin G; de Keyser J Neurosci Lett; 1994 Jul; 175(1-2):17-20. PubMed ID: 7970202 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the functional activity of dopamine ligands at human recombinant dopamine D4 receptors. Chabert C; Cavegn C; Bernard A; Mills A J Neurochem; 1994 Jul; 63(1):62-5. PubMed ID: 7911513 [TBL] [Abstract][Full Text] [Related]
16. Ligand Binding Pathways of Clozapine and Haloperidol in the Dopamine D2 and D3 Receptors. Thomas T; Fang Y; Yuriev E; Chalmers DK J Chem Inf Model; 2016 Feb; 56(2):308-21. PubMed ID: 26690887 [TBL] [Abstract][Full Text] [Related]
17. Dopamine D1 receptor mutagenesis: role of amino acids in agonist and antagonist binding. Tomic M; Seeman P; George SR; O'Dowd BF Biochem Biophys Res Commun; 1993 Mar; 191(3):1020-7. PubMed ID: 8466481 [TBL] [Abstract][Full Text] [Related]
18. [The affinities of mosapramine for the dopamine receptor subtypes in human cell lines expressing D2, D3 and D4 receptors]. Futamura T; Ohashi Y; Yano K; Takahashi Y; Haga K; Fukuda T Nihon Yakurigaku Zasshi; 1996 May; 107(5):247-53. PubMed ID: 8690306 [TBL] [Abstract][Full Text] [Related]
19. Electrostatic and aromatic microdomains within the binding-site crevice of the D2 receptor: contributions of the second membrane-spanning segment. Javitch JA; Ballesteros JA; Chen J; Chiappa V; Simpson MM Biochemistry; 1999 Jun; 38(25):7961-8. PubMed ID: 10387039 [TBL] [Abstract][Full Text] [Related]
20. The predicted 3D structure of the human D2 dopamine receptor and the binding site and binding affinities for agonists and antagonists. Kalani MY; Vaidehi N; Hall SE; Trabanino RJ; Freddolino PL; Kalani MA; Floriano WB; Kam VW; Goddard WA Proc Natl Acad Sci U S A; 2004 Mar; 101(11):3815-20. PubMed ID: 14999101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]